The Clinical Development and Operations team at PMV Pharmaceuticals is responsible for designing, implementing, and overseeing clinical trials to develop and validate p53 regulatory therapies for cancer treatment. This team ensures that studies are conducted efficiently, comply with regulatory standards, and translate preclinical findings into clinical success while maintaining rigorous quality assurance.
Arnold J. Levine
Co-Founder & Director
Charles M. Baum
Director
Charles Sawyers
Scientific Advisor
Frank Mccormick
Scientific Advisor
Karen Vousden
Scientific Advisor
Laura De Leon
VP & Head of Clinical Operatio...
Laurie Stelzer
Director
Richard A. Heyman
Chairman, Board of Directors
Scott Lowe
Chairman, Scientific Advisory ...
Thomas Shenk
Co-Founder & Scientific Adviso...
View all